Gene Symbol | Gene ID | Gene Info |
---|---|---|
Max
|
ENSMUSG00000059436.6 | Max protein |
Mycn
|
ENSMUSG00000037169.8 | v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_76957812_76958004 | Max | 3499 | 0.202901 | -0.54 | 2.0e-05 | Click! |
chr12_76947625_76947790 | Max | 5462 | 0.171281 | -0.43 | 1.1e-03 | Click! |
chr12_76948296_76948447 | Max | 4798 | 0.177815 | -0.41 | 1.8e-03 | Click! |
chr12_76930300_76930461 | Max | 9614 | 0.157824 | -0.41 | 2.1e-03 | Click! |
chr12_76948734_76949039 | Max | 4283 | 0.184548 | -0.38 | 4.3e-03 | Click! |
chr12_12940292_12940885 | Mycn | 28 | 0.965802 | 0.58 | 3.5e-06 | Click! |
chr12_12940979_12941180 | Mycn | 463 | 0.744253 | 0.56 | 8.9e-06 | Click! |
chr12_12941527_12942979 | Mycn | 339 | 0.830944 | 0.49 | 1.7e-04 | Click! |
chr12_12937894_12938297 | Mycn | 2521 | 0.197996 | 0.47 | 3.2e-04 | Click! |
chr12_12938393_12939271 | Mycn | 1784 | 0.258535 | 0.47 | 3.2e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_61225302_61226760 | 10.60 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr10_78464271_78465733 | 8.60 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr9_83806172_83806700 | 8.36 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr11_4572974_4574056 | 6.58 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr6_114968557_114970098 | 5.90 |
Vgll4 |
vestigial like family member 4 |
147 |
0.97 |
chr10_8348667_8348983 | 5.84 |
Ust |
uronyl-2-sulfotransferase |
46583 |
0.19 |
chr10_81429712_81431957 | 5.47 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr5_148398815_148400002 | 5.46 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
383 |
0.89 |
chr4_155409367_155409744 | 5.27 |
Cfap74 |
cilia and flagella associated protein 74 |
297 |
0.84 |
chr2_178630576_178630949 | 5.21 |
Cdh26 |
cadherin-like 26 |
170132 |
0.03 |
chr7_24883912_24885132 | 5.11 |
Rps19 |
ribosomal protein S19 |
111 |
0.92 |
chr7_19118025_19118835 | 5.07 |
Gm4969 |
predicted gene 4969 |
62 |
0.92 |
chr2_94273064_94274137 | 5.02 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr4_110050502_110051534 | 5.00 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr11_7213273_7214485 | 4.90 |
Igfbp3 |
insulin-like growth factor binding protein 3 |
18 |
0.98 |
chr8_36457363_36458468 | 4.88 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr8_105410767_105411240 | 4.85 |
Kctd19 |
potassium channel tetramerisation domain containing 19 |
2453 |
0.14 |
chrX_6046872_6047632 | 4.83 |
Nudt11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
201 |
0.92 |
chr7_12779870_12780809 | 4.82 |
Zscan18 |
zinc finger and SCAN domain containing 18 |
315 |
0.58 |
chr13_44232584_44232767 | 4.79 |
Gm47781 |
predicted gene, 47781 |
277 |
0.9 |
chr11_6528030_6529187 | 4.74 |
Snhg15 |
small nucleolar RNA host gene 15 |
155 |
0.75 |
chr17_25570380_25571317 | 4.72 |
Cerox1 |
cytoplasmic endogenous regulator of oxidative phosphorylation 1 |
4 |
0.66 |
chr1_38835547_38836894 | 4.62 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr15_93085264_93085415 | 4.59 |
Gm18685 |
predicted gene, 18685 |
3891 |
0.27 |
chr1_72823832_72824380 | 4.52 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
397 |
0.88 |
chr15_51828888_51829155 | 4.46 |
Eif3h |
eukaryotic translation initiation factor 3, subunit H |
7236 |
0.22 |
chr5_52565300_52566622 | 4.45 |
Lgi2 |
leucine-rich repeat LGI family, member 2 |
342 |
0.84 |
chr15_27782466_27782630 | 4.41 |
Trio |
triple functional domain (PTPRF interacting) |
6090 |
0.25 |
chrX_159414098_159414737 | 4.40 |
Map7d2 |
MAP7 domain containing 2 |
155 |
0.95 |
chr8_69881901_69882713 | 4.32 |
Cilp2 |
cartilage intermediate layer protein 2 |
5380 |
0.11 |
chr18_67464673_67465310 | 4.29 |
Prelid3a |
PRELI domain containing 3A |
100 |
0.95 |
chr1_89968155_89968712 | 4.24 |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
28019 |
0.16 |
chr2_151701768_151703133 | 4.19 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr12_102468744_102469733 | 4.18 |
Golga5 |
golgi autoantigen, golgin subfamily a, 5 |
46 |
0.97 |
chr4_31205584_31205906 | 4.15 |
Gm25705 |
predicted gene, 25705 |
30733 |
0.26 |
chr15_82274792_82275723 | 4.15 |
Septin3 |
septin 3 |
18 |
0.94 |
chr4_87570443_87570874 | 4.09 |
Gm12604 |
predicted gene 12604 |
10131 |
0.3 |
chr15_40169638_40170055 | 4.02 |
Gm33301 |
predicted gene, 33301 |
7239 |
0.19 |
chr10_81364518_81366962 | 3.89 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr8_84742133_84743295 | 3.85 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
19707 |
0.09 |
chr6_124964705_124965751 | 3.85 |
Cops7a |
COP9 signalosome subunit 7A |
21 |
0.92 |
chr13_40606396_40606745 | 3.82 |
Gm47039 |
predicted gene, 47039 |
91 |
0.97 |
chr13_58806713_58806907 | 3.78 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
171 |
0.92 |
chr10_77902919_77903521 | 3.74 |
Lrrc3 |
leucine rich repeat containing 3 |
684 |
0.44 |
chr9_21367360_21368059 | 3.70 |
Ilf3 |
interleukin enhancer binding factor 3 |
162 |
0.89 |
chr13_59011549_59011989 | 3.66 |
Gm34245 |
predicted gene, 34245 |
66527 |
0.09 |
chr9_41890642_41891131 | 3.64 |
Gm40513 |
predicted gene, 40513 |
282 |
0.9 |
chr3_89320460_89321321 | 3.63 |
Efna3 |
ephrin A3 |
741 |
0.37 |
chr17_13759899_13761731 | 3.60 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr6_25278174_25278333 | 3.58 |
Gm22529 |
predicted gene, 22529 |
78202 |
0.11 |
chr3_8511467_8511691 | 3.51 |
Stmn2 |
stathmin-like 2 |
1993 |
0.36 |
chr2_174109835_174111101 | 3.50 |
Npepl1 |
aminopeptidase-like 1 |
119 |
0.96 |
chr7_113765650_113766794 | 3.49 |
Spon1 |
spondin 1, (f-spondin) extracellular matrix protein |
48 |
0.98 |
chr10_39672573_39673015 | 3.48 |
Gm8899 |
predicted gene 8899 |
10705 |
0.13 |
chr2_119873204_119873534 | 3.46 |
Gm13998 |
predicted gene 13998 |
5034 |
0.17 |
chr14_76979791_76979942 | 3.46 |
Gm4291 |
predicted gene 4291 |
3617 |
0.27 |
chr7_99351180_99351446 | 3.46 |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
1684 |
0.3 |
chr17_55445850_55446443 | 3.45 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
98 |
0.98 |
chr8_54163625_54163799 | 3.45 |
Vegfc |
vascular endothelial growth factor C |
85933 |
0.1 |
chr12_3364588_3366025 | 3.44 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr17_27203606_27204996 | 3.41 |
Lemd2 |
LEM domain containing 2 |
168 |
0.9 |
chr4_107835452_107835981 | 3.41 |
Lrp8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
4731 |
0.12 |
chr2_61815550_61816375 | 3.40 |
Tbr1 |
T-box brain gene 1 |
9689 |
0.18 |
chr10_79874050_79875052 | 3.40 |
Plppr3 |
phospholipid phosphatase related 3 |
19 |
0.53 |
chr16_42172623_42172774 | 3.40 |
Gm49737 |
predicted gene, 49737 |
12219 |
0.2 |
chr5_35447977_35448221 | 3.40 |
Gm43377 |
predicted gene 43377 |
52001 |
0.09 |
chr2_102451171_102452295 | 3.39 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr3_108085301_108086522 | 3.39 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr13_51594988_51595203 | 3.37 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
25608 |
0.16 |
chr9_91355296_91356130 | 3.36 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
4760 |
0.12 |
chr9_49745768_49745983 | 3.33 |
Ncam1 |
neural cell adhesion molecule 1 |
52883 |
0.15 |
chr5_149513472_149514426 | 3.30 |
Gm2566 |
predicted gene 2566 |
10897 |
0.13 |
chr6_122560949_122561227 | 3.29 |
Aicda |
activation-induced cytidine deaminase |
603 |
0.56 |
chr10_84357932_84358418 | 3.29 |
Nuak1 |
NUAK family, SNF1-like kinase, 1 |
34213 |
0.15 |
chr6_51767840_51768297 | 3.27 |
Gm38811 |
predicted gene, 38811 |
56987 |
0.13 |
chr4_118620310_118621356 | 3.26 |
Ebna1bp2 |
EBNA1 binding protein 2 |
15 |
0.52 |
chr5_137313761_137314590 | 3.25 |
Trip6 |
thyroid hormone receptor interactor 6 |
11 |
0.94 |
chr10_81059624_81060601 | 3.25 |
Sgta |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
3 |
0.94 |
chr14_18238252_18238719 | 3.23 |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
526 |
0.71 |
chr1_84710201_84710701 | 3.22 |
Dner |
delta/notch-like EGF repeat containing |
14230 |
0.15 |
chr7_141070009_141070863 | 3.22 |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
161 |
0.88 |
chr6_55791826_55792546 | 3.20 |
Itprid1 |
ITPR interacting domain containing 1 |
44709 |
0.18 |
chr9_21072992_21073837 | 3.19 |
Fdx2 |
ferredoxin 2 |
92 |
0.74 |
chr5_121968476_121968865 | 3.19 |
Cux2 |
cut-like homeobox 2 |
33674 |
0.13 |
chr10_32889642_32890523 | 3.18 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
234 |
0.95 |
chr9_18473066_18474201 | 3.18 |
Zfp558 |
zinc finger protein 558 |
74 |
0.95 |
chr16_77788297_77788506 | 3.18 |
Gm17333 |
predicted gene, 17333 |
58203 |
0.11 |
chr2_25319011_25319403 | 3.16 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
20 |
0.93 |
chr12_49390233_49390661 | 3.14 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
212 |
0.91 |
chr13_92752098_92752295 | 3.14 |
Thbs4 |
thrombospondin 4 |
22778 |
0.17 |
chr9_56635860_56636539 | 3.13 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
571 |
0.77 |
chr18_36017856_36019112 | 3.13 |
Nrg2 |
neuregulin 2 |
13457 |
0.16 |
chr11_70655606_70656233 | 3.13 |
Gm12319 |
predicted gene 12319 |
574 |
0.38 |
chr10_78752255_78753176 | 3.11 |
Ccdc105 |
coiled-coil domain containing 105 |
350 |
0.8 |
chr17_56475522_56476833 | 3.11 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
192 |
0.93 |
chr2_31654085_31654541 | 3.11 |
Gm13424 |
predicted gene 13424 |
6157 |
0.11 |
chr12_16653394_16654346 | 3.11 |
Ntsr2 |
neurotensin receptor 2 |
112 |
0.96 |
chr17_56693837_56694281 | 3.10 |
Ranbp3 |
RAN binding protein 3 |
2676 |
0.16 |
chr19_47854442_47855082 | 3.10 |
Gsto1 |
glutathione S-transferase omega 1 |
208 |
0.92 |
chr1_136142237_136142876 | 3.10 |
Kif21b |
kinesin family member 21B |
11102 |
0.11 |
chr12_73416042_73416239 | 3.07 |
D830013O20Rik |
RIKEN cDNA D830013O20 gene |
6583 |
0.18 |
chr14_68197161_68197356 | 3.06 |
Gm47212 |
predicted gene, 47212 |
20995 |
0.18 |
chr4_73790618_73791250 | 3.05 |
Rasef |
RAS and EF hand domain containing |
60 |
0.8 |
chr5_45639206_45639588 | 3.04 |
9630001P10Rik |
RIKEN cDNA 9630001P10 gene |
16 |
0.73 |
chr8_122284023_122284944 | 3.03 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chrX_81070276_81071390 | 3.03 |
Tmem47 |
transmembrane protein 47 |
117 |
0.98 |
chr10_50911103_50911322 | 3.02 |
Sim1 |
single-minded family bHLH transcription factor 1 |
15561 |
0.26 |
chr13_73626497_73627526 | 3.02 |
Tert |
telomerase reverse transcriptase |
0 |
0.97 |
chr7_43606966_43607463 | 3.00 |
Zfp819 |
zinc finger protein 819 |
5 |
0.95 |
chr10_85829043_85829227 | 2.99 |
Pwp1 |
PWP1 homolog, endonuclein |
359 |
0.58 |
chr15_77955993_77956904 | 2.98 |
Foxred2 |
FAD-dependent oxidoreductase domain containing 2 |
227 |
0.9 |
chr3_116007285_116008437 | 2.97 |
Extl2 |
exostosin-like glycosyltransferase 2 |
33 |
0.88 |
chr4_74013078_74013818 | 2.97 |
Frmd3 |
FERM domain containing 3 |
4 |
0.98 |
chr2_10373964_10374187 | 2.95 |
Gm13261 |
predicted gene 13261 |
34 |
0.89 |
chr4_123677170_123677321 | 2.95 |
Macf1 |
microtubule-actin crosslinking factor 1 |
7115 |
0.14 |
chr12_3930272_3930423 | 2.95 |
Gm9088 |
predicted gene 9088 |
1693 |
0.3 |
chr2_119322485_119323040 | 2.95 |
Gm14207 |
predicted gene 14207 |
2781 |
0.16 |
chr6_51592327_51592791 | 2.94 |
Gm22914 |
predicted gene, 22914 |
29073 |
0.18 |
chr16_46009777_46011157 | 2.94 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr14_124677301_124677726 | 2.93 |
Fgf14 |
fibroblast growth factor 14 |
386 |
0.9 |
chr14_50924779_50925664 | 2.92 |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
64 |
0.78 |
chr7_105786596_105787077 | 2.91 |
Dchs1 |
dachsous cadherin related 1 |
716 |
0.5 |
chr13_99516425_99517155 | 2.91 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr10_81643079_81643993 | 2.90 |
Ankrd24 |
ankyrin repeat domain 24 |
267 |
0.8 |
chr14_60176584_60177406 | 2.90 |
Atp8a2 |
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
544 |
0.71 |
chr3_102979946_102980141 | 2.88 |
Sike1 |
suppressor of IKBKE 1 |
15665 |
0.12 |
chr2_158409115_158410592 | 2.86 |
Ralgapb |
Ral GTPase activating protein, beta subunit (non-catalytic) |
0 |
0.95 |
chr17_12289940_12290395 | 2.85 |
Gm49962 |
predicted gene, 49962 |
10050 |
0.13 |
chr11_32002527_32003111 | 2.84 |
Nsg2 |
neuron specific gene family member 2 |
2317 |
0.33 |
chr14_35112409_35112620 | 2.83 |
Gm49034 |
predicted gene, 49034 |
106924 |
0.07 |
chr4_20777672_20778960 | 2.82 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr9_22049819_22050263 | 2.82 |
Elavl3 |
ELAV like RNA binding protein 3 |
1969 |
0.15 |
chr17_48931454_48931677 | 2.82 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
814 |
0.75 |
chr5_142140102_142140271 | 2.80 |
Gm26970 |
predicted gene, 26970 |
142920 |
0.05 |
chr5_112227349_112227837 | 2.80 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
1048 |
0.39 |
chr4_110351157_110352032 | 2.79 |
Elavl4 |
ELAV like RNA binding protein 4 |
315 |
0.93 |
chrX_158923095_158923580 | 2.79 |
Gm5764 |
predicted gene 5764 |
89902 |
0.09 |
chr17_70308482_70308633 | 2.78 |
Dlgap1 |
DLG associated protein 1 |
116237 |
0.07 |
chr12_49401253_49401829 | 2.78 |
Gm48659 |
predicted gene, 48659 |
10707 |
0.13 |
chr7_19094759_19096427 | 2.77 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr18_89769896_89770072 | 2.77 |
Dok6 |
docking protein 6 |
456 |
0.87 |
chr6_117577960_117578123 | 2.76 |
Gm9946 |
predicted gene 9946 |
10369 |
0.2 |
chr5_45278590_45278909 | 2.76 |
Gm43303 |
predicted gene 43303 |
26820 |
0.18 |
chr8_75212715_75213244 | 2.75 |
Rasd2 |
RASD family, member 2 |
965 |
0.51 |
chr10_24765241_24765392 | 2.73 |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
19689 |
0.19 |
chr10_81473166_81473568 | 2.72 |
Celf5 |
CUGBP, Elav-like family member 5 |
11 |
0.93 |
chr8_88316500_88316952 | 2.72 |
Adcy7 |
adenylate cyclase 7 |
4469 |
0.22 |
chr19_24142818_24143047 | 2.72 |
Tjp2 |
tight junction protein 2 |
150 |
0.95 |
chr4_33587274_33587462 | 2.72 |
Gm23304 |
predicted gene, 23304 |
41593 |
0.18 |
chr10_81383963_81384933 | 2.70 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
11 |
0.48 |
chr12_109067556_109068192 | 2.70 |
Begain |
brain-enriched guanylate kinase-associated |
343 |
0.87 |
chr1_172375985_172377238 | 2.69 |
Pigm |
phosphatidylinositol glycan anchor biosynthesis, class M |
65 |
0.96 |
chr12_80518528_80519832 | 2.69 |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
190 |
0.58 |
chr2_3887922_3888113 | 2.69 |
Gm13180 |
predicted gene 13180 |
32987 |
0.15 |
chr15_74487345_74487780 | 2.69 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
28633 |
0.16 |
chr7_79505113_79505341 | 2.68 |
Mir9-3 |
microRNA 9-3 |
37 |
0.94 |
chr13_67332113_67332845 | 2.68 |
Zfp595 |
zinc finger protein 595 |
21 |
0.94 |
chr8_36142092_36142588 | 2.66 |
Gm38414 |
predicted gene, 38414 |
13670 |
0.15 |
chr3_116119158_116119497 | 2.66 |
Vcam1 |
vascular cell adhesion molecule 1 |
1388 |
0.33 |
chr5_33995599_33996957 | 2.66 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chrX_13207639_13208350 | 2.66 |
Rpl3-ps1 |
ribosomal protein L3, pseudogene 1 |
5423 |
0.11 |
chr1_18058368_18058994 | 2.65 |
Gm28756 |
predicted gene 28756 |
109 |
0.82 |
chr5_142367069_142368113 | 2.65 |
Foxk1 |
forkhead box K1 |
33906 |
0.18 |
chr8_83667823_83669013 | 2.65 |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
1276 |
0.29 |
chr11_90417658_90418322 | 2.64 |
Hlf |
hepatic leukemia factor |
27095 |
0.21 |
chr10_80131216_80131749 | 2.63 |
Cbarp |
calcium channel, voltage-dependent, beta subunit associated regulatory protein |
3199 |
0.11 |
chr6_91284995_91285433 | 2.62 |
Fbln2 |
fibulin 2 |
19335 |
0.17 |
chr15_100914746_100914933 | 2.61 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
18590 |
0.18 |
chr3_55353905_55354441 | 2.61 |
Dclk1 |
doublecortin-like kinase 1 |
39 |
0.97 |
chr15_76461282_76462583 | 2.60 |
Scx |
scleraxis |
4412 |
0.09 |
chr11_86807230_86808078 | 2.60 |
Dhx40 |
DEAH (Asp-Glu-Ala-His) box polypeptide 40 |
92 |
0.98 |
chr2_104318948_104319106 | 2.60 |
Gm13882 |
predicted gene 13882 |
27453 |
0.14 |
chr7_115258761_115258930 | 2.59 |
Gm27684 |
predicted gene, 27684 |
86572 |
0.09 |
chr10_79636972_79637781 | 2.59 |
Gm47163 |
predicted gene, 47163 |
480 |
0.42 |
chr13_14522874_14523297 | 2.59 |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
20 |
0.92 |
chr5_43672445_43672857 | 2.58 |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
362 |
0.86 |
chr7_81454347_81455042 | 2.58 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
19 |
0.95 |
chr1_120602158_120602362 | 2.58 |
En1 |
engrailed 1 |
158 |
0.96 |
chr6_147061739_147061930 | 2.57 |
Mrps35 |
mitochondrial ribosomal protein S35 |
583 |
0.66 |
chr3_158559264_158559584 | 2.57 |
Lrrc7 |
leucine rich repeat containing 7 |
1912 |
0.47 |
chr14_57525179_57526034 | 2.56 |
Il17d |
interleukin 17D |
829 |
0.55 |
chr5_146385366_146385636 | 2.56 |
Wasf3 |
WAS protein family, member 3 |
516 |
0.79 |
chr2_77816275_77817277 | 2.55 |
Zfp385b |
zinc finger protein 385B |
40 |
0.98 |
chr2_25240744_25241709 | 2.55 |
Cysrt1 |
cysteine rich tail 1 |
1226 |
0.15 |
chr3_52520623_52520778 | 2.54 |
Gm30173 |
predicted gene, 30173 |
3736 |
0.3 |
chr5_26903905_26905035 | 2.54 |
Dpp6 |
dipeptidylpeptidase 6 |
225 |
0.95 |
chr8_58912252_58913386 | 2.54 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
179 |
0.83 |
chrX_42361483_42361664 | 2.53 |
Gm14619 |
predicted gene 14619 |
14061 |
0.27 |
chr12_108327889_108328514 | 2.52 |
4930478K11Rik |
RIKEN cDNA 4930478K11 gene |
171 |
0.94 |
chr1_13189266_13189438 | 2.52 |
Gm38376 |
predicted gene, 38376 |
9638 |
0.16 |
chr7_96474512_96474810 | 2.52 |
Rps11-ps5 |
ribosomal protein S11, pseudogene 5 |
38644 |
0.17 |
chr1_154723189_154723396 | 2.52 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
2628 |
0.42 |
chr2_36090945_36091826 | 2.52 |
Lhx6 |
LIM homeobox protein 6 |
2888 |
0.18 |
chr4_21930986_21931430 | 2.52 |
Faxc |
failed axon connections homolog |
121 |
0.97 |
chr8_109464450_109464637 | 2.51 |
Pmfbp1 |
polyamine modulated factor 1 binding protein 1 |
29484 |
0.16 |
chr13_52501719_52501870 | 2.50 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
29485 |
0.23 |
chr5_111581561_111581798 | 2.50 |
C130026L21Rik |
RIKEN cDNA C130026L21 gene |
111 |
0.97 |
chr6_22984216_22984575 | 2.50 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
1914 |
0.44 |
chr9_15357669_15358342 | 2.49 |
Cep295 |
centrosomal protein 295 |
217 |
0.81 |
chr6_93792884_93793099 | 2.48 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
452 |
0.66 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.3 | 6.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.1 | 6.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.9 | 5.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.6 | 4.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.5 | 7.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.5 | 4.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.5 | 4.4 | GO:0021586 | pons maturation(GO:0021586) |
1.4 | 9.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.4 | 5.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.4 | 8.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 4.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.3 | 4.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.3 | 2.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.3 | 4.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.3 | 1.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.3 | 3.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.3 | 8.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.3 | 2.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.2 | 7.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.2 | 3.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.2 | 2.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.2 | 5.8 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.2 | 1.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 4.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.1 | 4.5 | GO:0061743 | motor learning(GO:0061743) |
1.1 | 3.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.1 | 1.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.1 | 3.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.0 | 4.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.0 | 2.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.0 | 2.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.0 | 2.0 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
1.0 | 3.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.0 | 4.0 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.0 | 3.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.0 | 6.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 2.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.0 | 2.9 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.0 | 2.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.9 | 0.9 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.9 | 2.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.9 | 3.7 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.9 | 3.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 2.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 2.7 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 2.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.9 | 2.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.9 | 2.6 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.9 | 2.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.9 | 2.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 2.5 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.8 | 2.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 6.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.8 | 2.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 3.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.8 | 2.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 2.5 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.8 | 1.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.8 | 3.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.8 | 2.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.8 | 3.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.8 | 3.3 | GO:0046959 | habituation(GO:0046959) |
0.8 | 3.2 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 0.8 | GO:0051794 | regulation of catagen(GO:0051794) |
0.8 | 4.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 1.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.8 | 1.6 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.8 | 1.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.8 | 1.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.8 | 1.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 3.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.7 | 3.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.7 | 3.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 3.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 1.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.7 | 5.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.7 | 1.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 0.7 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.7 | 2.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.7 | 2.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 1.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.7 | 2.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 3.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.7 | 2.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 2.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.7 | 2.8 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.7 | 2.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.7 | 2.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.7 | 2.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 2.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 0.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.7 | 2.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.6 | 13.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 0.6 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.6 | 2.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 1.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.6 | 1.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 2.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.6 | 4.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.6 | 1.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.6 | 1.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 2.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.6 | 3.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.6 | 1.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 0.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.6 | 2.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.6 | 1.2 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.6 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.6 | 2.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 2.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 | 1.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.6 | 2.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.6 | 1.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 0.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.6 | 1.2 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.6 | 4.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.6 | 1.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 2.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 4.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.6 | 2.8 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 0.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.6 | 0.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.6 | 2.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 1.7 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.6 | 2.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 3.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.5 | 0.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.5 | 2.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 2.2 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 1.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 0.5 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.5 | 3.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 1.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.5 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 2.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 1.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.6 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 1.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 1.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 1.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 1.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 1.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 1.0 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.5 | 1.5 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.5 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.5 | 3.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 1.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 2.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.5 | 2.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 5.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 2.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 2.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 2.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 0.5 | GO:1903365 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.5 | 1.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 1.9 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.5 | 5.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.5 | 1.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 1.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 1.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 1.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.5 | 1.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 0.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.5 | 2.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 0.9 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.5 | 0.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 1.4 | GO:1901656 | glycoside transport(GO:1901656) |
0.5 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 4.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 1.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.5 | 2.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 1.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.5 | 1.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.5 | 1.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 3.6 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.4 | 1.8 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 2.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.4 | 0.4 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.4 | 1.8 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 4.8 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 0.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 3.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 1.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 1.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 0.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 1.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 1.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 1.3 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 0.8 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 1.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 3.7 | GO:0097369 | sodium ion import(GO:0097369) |
0.4 | 2.1 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.4 | 0.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.4 | 1.2 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.4 | 4.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 5.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 4.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 0.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 1.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 0.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.4 | 0.8 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.4 | 4.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 0.4 | GO:0046958 | nonassociative learning(GO:0046958) |
0.4 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 0.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 1.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.4 | 1.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 2.7 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.4 | 0.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.4 | 0.4 | GO:0098597 | observational learning(GO:0098597) |
0.4 | 0.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 2.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 1.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.4 | 1.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 1.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.4 | 2.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 0.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 1.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 1.9 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 1.1 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.4 | 1.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 3.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 1.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 0.7 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.4 | 0.7 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 1.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 0.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.4 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 1.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 0.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.4 | 1.1 | GO:0042637 | catagen(GO:0042637) |
0.4 | 2.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 9.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 2.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 1.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 1.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 1.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 2.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 1.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.3 | 1.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.3 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 2.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 1.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 1.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 2.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.3 | 0.7 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.3 | 1.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 6.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 2.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 1.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 0.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 0.6 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 1.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 3.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.3 | 1.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 1.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 2.2 | GO:0060914 | heart formation(GO:0060914) |
0.3 | 0.9 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.6 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 2.8 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 1.9 | GO:0001975 | response to amphetamine(GO:0001975) |
0.3 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 0.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 1.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 3.6 | GO:0060384 | innervation(GO:0060384) |
0.3 | 3.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.3 | 0.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 2.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 4.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 0.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 1.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 3.0 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.3 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.3 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 2.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 1.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 3.4 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.3 | 0.8 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.3 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.3 | 2.8 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.3 | 4.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 1.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.4 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.3 | 0.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 0.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 0.3 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.3 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.3 | 1.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 1.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 20.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 1.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 1.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 3.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 2.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 4.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.8 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 0.5 | GO:0002118 | aggressive behavior(GO:0002118) |
0.3 | 1.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 1.5 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.3 | 1.5 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 1.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.7 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 1.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.5 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.9 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.9 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 10.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.7 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.9 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.2 | GO:0003150 | membranous septum morphogenesis(GO:0003149) muscular septum morphogenesis(GO:0003150) |
0.2 | 0.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.2 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.2 | 0.2 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.2 | 0.9 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 1.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.9 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.2 | 1.1 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 1.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.9 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 1.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.8 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 1.4 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.2 | 1.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.8 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.8 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.2 | 0.4 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 2.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 4.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 2.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 1.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 1.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.4 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.8 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.4 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.2 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.4 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.2 | 1.5 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 0.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.4 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.6 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.2 | 3.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 2.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.4 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 0.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 1.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.3 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.2 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.2 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.3 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.2 | 0.2 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.2 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 1.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 1.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.2 | 0.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.3 | GO:0072044 | collecting duct development(GO:0072044) |
0.2 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.5 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 1.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.9 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.6 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 1.7 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 1.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.5 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 1.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 1.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 4.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.4 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 1.7 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 12.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 1.6 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
0.1 | 0.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 1.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 1.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 0.3 | GO:2000589 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) regulation of metanephric mesenchymal cell migration(GO:2000589) |
0.1 | 1.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 1.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 2.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.5 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.1 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 0.2 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 1.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.1 | GO:0072275 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.1 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.6 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 1.3 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 1.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.4 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.1 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 6.4 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 1.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 5.0 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.1 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.4 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 4.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.2 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.2 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.1 | 0.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 1.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.3 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.9 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.1 | 0.1 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.2 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 1.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 1.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 1.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.0 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.0 | 0.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.0 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.0 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.0 | 0.2 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.0 | 0.4 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.1 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0043476 | pigment accumulation(GO:0043476) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.2 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.0 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0061440 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.3 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.4 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.0 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.2 | 9.5 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 3.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 4.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.9 | 4.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 0.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.9 | 3.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 2.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 2.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.8 | 1.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 2.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.8 | 4.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 6.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 7.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 20.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 5.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 3.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 2.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.6 | 1.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 1.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 10.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 2.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 3.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 21.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 1.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 4.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 1.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 3.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 0.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 1.2 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 0.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 2.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 2.4 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.4 | 18.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 1.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 21.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 0.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 4.9 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 7.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 3.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 3.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 5.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 3.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 2.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 8.4 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 3.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 1.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 2.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 30.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 2.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.9 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.2 | 4.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 2.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.6 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 27.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.5 | GO:0044298 | cell body membrane(GO:0044298) |
0.2 | 2.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 2.7 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 1.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 4.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.9 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.8 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 3.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.7 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 3.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 12.1 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 3.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 5.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 4.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.3 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 23.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 3.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 3.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 2.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 2.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 1.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.8 | 7.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.5 | 12.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.4 | 5.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.3 | 6.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 8.8 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.1 | 4.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.1 | 5.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 8.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 2.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.0 | 11.2 | GO:0016595 | glutamate binding(GO:0016595) |
1.0 | 4.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 2.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 4.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 4.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 2.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.9 | 2.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.8 | 2.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.8 | 2.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 2.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 2.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 4.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.8 | 2.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 8.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 2.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 2.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 2.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.7 | 2.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 1.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.7 | 6.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.7 | 5.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.7 | 2.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 10.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.7 | 1.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.7 | 2.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.7 | 3.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 3.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.6 | 2.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 1.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 3.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 4.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 11.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.6 | 2.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.6 | 3.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.6 | 1.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 3.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 4.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 2.2 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.5 | 2.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 2.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 1.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 2.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.5 | 2.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 1.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 3.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 2.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 2.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 1.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 2.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 1.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 7.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.5 | 1.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 3.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 2.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 0.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.4 | 1.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 1.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 13.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 4.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 1.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 3.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.4 | 2.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 0.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 2.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 6.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 1.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 9.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 21.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 1.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 1.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 1.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 4.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 5.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 0.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.4 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 5.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 1.4 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 1.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 1.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 3.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 0.7 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 1.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 8.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.3 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 5.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 1.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 0.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 4.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 3.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 1.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.3 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 2.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 5.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 1.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 8.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 6.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 2.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 2.1 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 1.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 5.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 3.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 3.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 2.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 2.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.2 | 1.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.6 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 4.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 2.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 2.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 5.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 7.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 6.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 3.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 2.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 1.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 4.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 2.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.7 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 5.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 4.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 4.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 1.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 2.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.4 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 2.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 1.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 11.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 4.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.4 | GO:0099528 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 23.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.0 | GO:0008758 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 2.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 2.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 2.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 2.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 4.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.7 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.9 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 1.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 1.3 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.7 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.7 | 0.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 11.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 3.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 0.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 5.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 1.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 6.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 4.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 4.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 32.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 2.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 42.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 3.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 3.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 4.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 3.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 8.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 15.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 11.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 9.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 2.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.5 | 1.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 6.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 20.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 5.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 8.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 4.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 4.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 15.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 3.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 3.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 5.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 2.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 1.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 5.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 2.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 2.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 5.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 7.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 1.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 7.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 2.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 5.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 1.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 3.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 5.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 4.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 2.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 4.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 3.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 7.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 3.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 5.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 0.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 3.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.5 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 3.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 6.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 4.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 2.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 3.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 2.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.4 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 4.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 3.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 4.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 2.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 4.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 2.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |